* All development phases not applicable for 505(b)2 regulatory filings.
** See warnings and full prescribing information. Marketed in the U.S. by Meda Pharmaceuticals.
*** Licensed worldwide to Endo Health Solutions.
TECHNOLOGY PLATFORM MENU
TOP NEWS
VIDEO